Neurosurgical FOCUS · 2006 · 58 citations · 36 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyOncology PharmacotherapyAntioxidant DefenseGlioma RadiotherapyOncology PharmacologyOxidative Stress MechanismsReactive Oxygen SpeciesRedox Metabolism In DiseaseCellular Oxidative Stress ResponseCellular Response To Oxidative StressGlioblastoma ChemotherapyGlioblastoma Drug TherapyOxidative Stress In CancerOxidative Stress InjuryRadiation-induced Oxidative StressTreatment Of Malaria
Chloroquine is used in the treatment of malaria, a disease caused by infection with the parasite Plasmodium. Although chloroquine appears to possess diverse pharmacological activity, its plasmodicidal activity results from augmentation of parasite oxidative stress. Chloroquine also appears to augment oxidative stress in metabolically active mammalian cells, including human astroglial cells. The authors propose that chloroquine may augment oxidative stress induced by radiotherapy in the treatment of glioblastoma multiforme, enhancing therapeutic efficacy. Such an effect would be consistent with the known pharmacological effects of chloroquine observed in Plasmodium. Other selective redox agents, such as tempol and artemisinin, should be investigated clinically for therapeutic benefit when coadministered with combined radio- and chemotherapy for cancer.
36
René-Olivier Mirimanoff, Thierry Gorlia, Warren Mason et al. · Journal of Clinical Oncology · 2006 · 508 citations
Oxidative stress in malignant melanoma and non-melanoma skin cancer
Christina S. Sander, Florian Hamm, Peter Elsner et al. · British Journal of Dermatology · 2003 · 294 citations
Medicine, Dermatology, Oncology +17